According to Straits Research, the global wound care biologics market size was valued at USD 1.77 Billion in 2022.
It is projected to reach from USD XX Billion in 2023 to USD 4.10 Billion by 2031, growing at a CAGR of 9.74% during the forecast period (2023–2031).